Forward-looking statements involve risks anduncertainties, including, without limitation, risks inherent in the developmentand/or commercialization of potential products, uncertainty in the results ofclinical trials or regulatory approvals, need and ability to obtain futurecapital, application of capital resources among competing uses, and maintenanceof intellectual property rights. Anystatements that are not historical fact (including, but not limited tostatements that contain words such as "will," "believes," "plans,""anticipates," "expects," "estimates,") should also be considered to beforward-looking statements. ISCO also produces and markets specialized cells and growth mediaworldwide for therapeutic research through its subsidiary Lifeline CellTechnology. For more information, visit the ISCO website at:. To subscribe to receive ongoing corporate communications please click on thefollowing link: http:// FORWARD-LOOKING STATEMENTS:Statements pertaining to anticipated future financial and/or operating results,future growth in research, technology, clinical development and potential jointventure and other opportunities for the company and its subsidiary, along withother statements about the future expectations, beliefs, goals, plans, orprospects expressed by management constitute forward-looking statements. ISCO scientists have created the firstParthenogenetic homozygous stem cell line (phSC-Hhom-4) that can be a source oftherapeutic cells that will minimize immune rejection after transplantation intohundreds of millions of individuals of differing sexes, ages and racial groups.These advancements offer the potential to create the first true "Stem Cell Bank"and address ethical issues by eliminating the need to use or destroy fertilizedembryos.

ISCO`s technology,Parthenogenesis, results in the creation of pluripotent human stem cell linesfrom unfertilized human eggs. "I am just refocusing myefforts where I believe I can be of the greatest help to the company`s future." For more news and information on International Stem Cell Corporation pleasevisit where you can find the CEO`s video, a fact sheeton the company, investor presentations, and more.ABOUT INTERNATIONAL STEM CELL CORPORATION (ISCO.OB):International Stem Cell Corporation is a California biotechnology companyfocused on developing therapeutic and research products. Adams has also elected to resign from the Board of Directors, effective June30, 2009, and will assist the Company in seeking an outside Board member withrelevant industry and regulatory affairs experience to fill the vacant seat "Iam by no means leaving the Company," said Mr Adams. Adams is responsible for much of the company`s financing to date,and this change will allow him to focus more effectively on future needs of theCompany, particularly in establishing new industry and research collaborations.Mr.

He will now work fulltime on developing new capital sources and collaborative opportunities for theCompany Mr. Mr.Wood has extensive public and private company experience that is expected toenhance ISCO`s financial and accounting strength Mr. Wood`s appointment will also permit William Adams, a founder of the Companyto step down from his role as CFO as of June 30, 2009. "As ISCO andLifeline have grown, the demands have increased," said Mr Janus "The additionof Dr. Semetchkine to the senior management of ISCO will add tremendous strengthto our strategic planning and management capabilities as we move forward towardstherapeutic use of our parthenogenetic stem cells and to help us manage theexpansion of both ISCO and Lifeline more effectively." In a final change, Ray Wood, who had been the controller of the company, hasbeen promoted to Vice President, Finance and Principal Financial Officer. Jeffrey Janus, will continue to be CEO and President of Lifeline CellTechnology, the revenue generating subsidiary of ISCO, and will also serve asSenior Vice President of Operations for the parent Company, ISCO. Semetchkine, a resident of Southern California, has been for manyyears a member of the prestigious Russian Academy of Sciences, the highestscientific body in Russia, and has been a founder or senior executive of manyinternational businesses "Dr.